BioSpace News Archive

BioForest

CTI BioPharma Announces Closing of Underwritten Public Offering of Common Stock

The expected proceeds to CTI BioPharma from the offering are approximately $64.2M.

February 13, 2018

·

5 min read

Pharm Country

Newron Supports Global Rare Disease Day 2018 and Rett Syndrome Studies

Observed on February 28, Rare Disease Day helps raise awareness of rare diseases, and in turn improve access to treatments.

February 13, 2018

·

8 min read

Genetown

CureVac to Pursue Innovative mRNA Vaccines Against Flu and Malaria

CureVac today announced the awarding of two new grants from the Bill & Melinda Gates Foundation.

February 13, 2018

·

4 min read

Business

Q BioMed Adds Big Pharma Executive to Board of Directors

Q Biomed is pleased to welcome Dr. Rick Panicucci as an independent member on its board of Directors.

February 13, 2018

·

3 min read

Drug Development

MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer

The interim study data show that ME-344 was generally well-tolerated and, consistent with previous preclinical data, demonstrate the potential to reverse resistance to antiangiogenic therapy.

February 13, 2018

·

5 min read

Drug Development

Sangamo Presents Oncology Genome Editing Capabilities at Keystone Symposium on Emerging Cellular Therapies

Sangamo yesterday presented preclinical data demonstrating the Company’s engineering capabilities in T cell genome editing using zinc finger nucleases.

February 13, 2018

·

6 min read

Lone Star Bio

Orthofix Announces Initiation of Enrollment in Rotator Cuff Repair Study

This study will assess the efficacy and safety of the Company’s RCStim device as an adjunctive treatment to surgical repair of full thickness rotator cuff tears.

February 13, 2018

·

4 min read

Bio NC

DebMed Offers Triclosan Alternatives Following FDA’s Healthcare Antiseptic Final Rule

In light of the U.S. Food and Drug Administration’s (FDA) long-expected final rule requiring triclosan to be phased out of antimicrobial soaps, DebMed is offering healthcare institutions a complete product suite of triclosan alternatives available immediately.

February 13, 2018

·

3 min read

Genetown

ReForm Biologics Secures New Patent Expanding Coverage of Key Excipient Formulation for Antibody-Based Therapeutics

ReForm Biologics, a pharmaceutical technology company developing innovative platforms to improve biologic formulations, expanded its patent portfolio with the issuance of U.S. Patent No. 9,867,881 (the ‘881 patent).

February 13, 2018

·

1 min read

Biotech Bay

Catalyst Biosciences Announces Proposed Public Offering of Common Stock - Feb. 13, 2018

All of the shares in the offering are to be sold by the Company.

February 13, 2018

·

3 min read